41.11
41.11 (0%)
As of Feb 14, 2025
Veracyte, Inc. [VCYT]
Source:
Company Overview
Veracyte, Inc. is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. Our high-performing tests enable clinicians to make more confident diagnostic, prognostic and treatment decisions.
| Country | United States |
| Headquarters | south san francisco, california |
| Phone Number | (650) 243-6300 |
| Industry | services |
| CEO | Marc Stapley |
| Website | www.veracyte.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $445.8 |
| Operating Profit | $16.1 |
| Net Income | $24.1 |
| Net Cash | $23.3 |
Profit Ratios
| Gross Margin | $298.1 |
| Operating Margin | 3.6 |
| Profit as % of Revenues | 1,235.2% |
| Profit as % of Assets | 2% |
| Profit as % of Stockholder Equity | 2.1% |
Management Effectiveness
| Return on Equity | 2.1% |
| Return on Assets | 1.9% |
| Turnover Ratio | 36.9% |
| EBITA | $16.1 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,300 |
| Total Liabilities | $124.1 |
| Operating Cash Flow | $75.1 |
| Investing Cash Flow | $-56.3 |
| Financing Cash Flow | $4.9 |
